SCHEMBL23959278

SCHEMBL23959278

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(C)cc(-c2ccn3c(-c4ccccc4)c(-c4ccccc4)nc3n2)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 10/20 0.46
▸ AKT2 P31751 9/20 0.46
▸ DHODH Q02127 1/20 0.37
▸ MAPK13 O15264 4/20 0.36
▸ MAPK12 P53778 4/20 0.36
▸ MAPK11 Q15759 4/20 0.36
▸ MAPK14 Q16539 4/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ USP2 O75604 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959286 0.90 AKT1 (0.45) AKT1AKT2DHODHMAPK13MAPK12
SCHEMBL23959306 0.88 AKT1 (0.50) AKT1AKT2DHODHMAPK13MAPK12
SCHEMBL23959252 0.84 AKT1 (0.43) AKT1AKT2DHODHMAPK13MAPK12
SCHEMBL23959301 0.84 AKT2 (0.46) AKT1AKT2MAPTSMN1; SMN2TP53
SCHEMBL23959214 0.82 AKT1 (0.45) AKT1AKT2DHODHKDM4EMAPT
SCHEMBL23959119 0.80 AKT1 (0.47) AKT1AKT2
SCHEMBL23959303 0.80 AKT1 (0.47) AKT1AKT2MAPK13MAPK12MAPK11
SCHEMBL23959280 0.78 AKT1 (0.53) AKT1AKT2MAPK13MAPK12MAPK11
SCHEMBL17449605 0.77 L3MBTL1 (0.42) DHODHKDM4EMEN1KMT2AL3MBTL1
SCHEMBL23959285 0.76 AKT1 (0.51) AKT1AKT2MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885DHODH 4051/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885DHODH 4051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback